Dr. M. Shaalan Beg joined the Division of Hematology/Medical Oncology specializing in cancers of the gastrointestinal tract. After receiving his medical training at the Aga Khan University in Karachi, Pakistan, he proceeded to complete his Internal Medicine residency and Hematology/Medical Oncology fellowship at the University of Cincinnati.
Dr. Beg’s clinical and research focus is on early-phase drug development and clinical trials for gastrointestinal cancers. He is an active member of the GI Cancers Disease Oriented Team and believes in true multidisciplinary care of his patients.
- Medical School
- Aga Khan Univ, Pakistan (2003)
- University of Cincinnati College of Medicine (2008), Internal Medicine
- University of Cincinnati (2011), Hematology Oncology
- Cancers of the gastrointestinal tract
- Early phase drug development, Phase I/II clinical trials
- Experimental therapeutics
- Peritoneal diseases
- Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States.
- Tan D, Yopp A, Beg MS, Gopal P, Singal AG Aliment. Pharmacol. Ther. 2013 Aug
- Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.
- Komrokji RS, Matacia-Murphy GM, Al Ali NH, Beg MS, Safa MM, Rollison DE, List AF Leuk. Res. 2010 Jan 34 1 59-62
- Predictive factors for early aspiration in liver abscess.
- Khan R, Hamid S, Abid S, Jafri W, Abbas Z, Islam M, Shah H, Beg S, World J. Gastroenterol. 2008 Apr 14 13 2089-93
Honors & Awards
- Resident Teacher Award
University of Cincinnati (2008)
- American Association for Cancer Research (2011)
- American Society of Clinical Oncology (2008)